Old Web
English
Sign In
Acemap
>
authorDetail
>
Azhar Z. Khan
Azhar Z. Khan
Eli Lilly and Company
Ramucirumab
Placebo
Population
Medicine
Pharmacokinetics
3
Papers
73
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Exposure-Response Analyses of Ramucirumab from Two Randomized, Phase III Trials of Second-Line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer
2017
Molecular Cancer Therapeutics
Josep Tabernero
Atsushi Ohtsu
Kei Muro
Eric Van Cutsem
Sang Cheul Oh
Gyorgy Bodoky
Yasuhiro Shimada
Shuichi Hironaka
Jaffer A. Ajani
Jiri Tomasek
Howard Safran
Kumari Chandrawansa
Yanzhi Hsu
Michael Heathman
Azhar Z. Khan
Lan Ni
Allen S. Melemed
Ling Gao
David Ferry
Charles S. Fuchs
Show All
Source
Cite
Save
Citations (22)
A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours
2007
Investigational New Drugs
Tara Baetz
Elizabeth Eisenhauer
Lillian L. Siu
Martha MacLean
Karen Doppler
Wendy Walsh
B. Fisher
Azhar Z. Khan
Dinesh P. de Alwis
Aaron Weitzman
Leslie H. Brail
Malcolm A. Moore
Show All
Source
Cite
Save
Citations (31)
1